Clinical Topics

Surgical Staging Often Inadequate for Gallbladder Cancer

by U.S. Medicine

February 24, 2019

HOUSTON–Guidelines frequently aren’t followed when it comes to radical cholecystectomy with regional lymphadenectomy for patients with T1b gallbladder cancer.

Current clinical practice guidelines recommend radical cholecystectomy with RC-RL for T1 GBC patients. A study in Annals of Surgical Oncology said it remains unclear the extent to which these guidelines are followed, however.1

Researchers from the Michael E. DeBakey VAMC and the Baylor College of Medicine, both in Houston, sought to evaluate current surgical practices for T1b GBC and those affecting overall management strategies and associated outcomes.

Their retrospective cohort study investigated patients identified from the National Cancer Data Base from 2004-2012 with nonmetastatic T1b GBC. Patients were categorized based on type of surgical treatment received: simple cholecystectomy or RC-RL. In addition, among patients who had lymph nodes pathologically examined, nodal status was classified as pN- or pN+.

The study team also determined use of any adjuvant therapy and compared overall survival based on type of surgical treatment and nodal status. Participants were 464 patients–247 SC and 217 RC-RL cases.

Results indicated that positive margin status did not differ between the two groups–6.1% for SC vs. 2.3% for RC-RL; p = 0.128. For RC-RL, the pN+ rate was 15%.

The study determined that adjuvant therapies were used more frequently in pN+ cases–53.1% vs. 9.4% for pN-, and that, by comparison, 10.9% of the SC patients received adjuvant therapy.

Overall survival for RC-RL-pN-, calculated as 64.4% reaching five years, was significantly better than for RC-RL-pN+, where only 15.7% reached five years or SC, were 48.3% achieved five years.

“Less than 50% of the patients with a T1b GBC primary tumor undergo the recommended surgical treatment,” study authors wrote. “Given that 15% of these patients have nodal metastasis and in light of the previously described benefits of adjuvant therapy for node positive GBC, failure to perform RC-RL risks incomplete staging and thus undertreatment for patients with T1b GBC.”

1. Vo E, Curley SA, Chai CY, Massarweh NN, Tran Cao HS. National Failure of Surgical Staging for T1b Gallbladder Cancer. Ann Surg Oncol. 2018 Nov 29. doi: 10.1245/s10434-018-7064-7. [Epub ahead of print] PubMed PMID: 30499077.


Comments are closed here.


Related Articles

Effective Metrics Help VA Exceed National Goal for Colorectal Cancer Screening

More Than 80% of Patients Meet Recommendations LOS ANGELES—More than four out of five veterans eligible for colorectal cancer screening have been screened, putting the largest healthcare system in the United States among the top... View Article

More Options, Better Survival for Veterans With Metastatic Pancreatic Cancer

ALBANY, NY—Pancreatic cancer remains one of the deadliest malignancies in the United States, but new therapies can extend life and improve quality of life for many patients. That is especially the case at the VA,... View Article


U.S. Medicine Recommends


More From oncology

Oncology

Effective Metrics Help VA Exceed National Goal for Colorectal Cancer Screening

More Than 80% of Patients Meet Recommendations LOS ANGELES—More than four out of five veterans eligible for colorectal cancer screening have been screened, putting the largest healthcare system in the United States among the top... View Article

Oncology

More Options, Better Survival for Veterans With Metastatic Pancreatic Cancer

ALBANY, NY—Pancreatic cancer remains one of the deadliest malignancies in the United States, but new therapies can extend life and improve quality of life for many patients. That is especially the case at the VA,... View Article

Oncology

Military Risks for Ocular Surface Squamous Neoplasia

MIAMI—While a variety of risk factors have been evaluated in ocular surface squamous neoplasia, few studies have assessed risk factors specific to the armed forces veteran population. A report in the journal Eye and Vision... View Article

Oncology

Antibiotics Appear to Inhibit Tumor Activity in CTCL

AARHUS, DENMARK—Do CD4 T cell responses to  Staphylococcus aureus inadvertently enhance neoplastic progression in models of skin cancer and cutaneous T cell lymphoma? A prospective study in the journal Blood examined that question, exploring the... View Article

Oncology

Lower Dose Cisplatin Preferable in Squamous Cell Carcinoma

PHILADELPHIA—Chemoradiotherapy is commonly used for nonoperative treatment of locally advanced head and neck squamous cell carcinoma. The issue, according to a recent study, is that the standard dose of 100 mg/m2 cisplatin every three weeks is... View Article

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up